Pediatric Hematology and Oncology

Papers
(The TQCC of Pediatric Hematology and Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
The role of pediatric oncologist in prenatal diagnosis: A 10-year retrospective study at Assistance Publique Hôpitaux de Marseille (AP-HM)13
The pre-surgical factors that determine the decision to proceed to resection in children diagnosed with high-risk neuroblastoma in a resource limited setting12
Environmental health disparities in pediatric cancer: a report from the Fourth Symposium on Childhood Cancer Health Disparities12
MicroRNA-199a deficiency relates to higher bone marrow blasts, poor risk stratification and worse prognostication in pediatric acute myeloid leukemia patients11
Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature10
Aceruloplasminemia presenting with microcytic anemia in a Turkish boy due to a novel pathogenic variant10
Clofarabine monotherapy in refractory multisystem LCH with gastrointestinal involvement10
Myelofibrosis associated with immune cytopenia in an infant: a diagnostic and therapeutic challenge9
Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis9
Response to neoadjuvant selpercatinib in a pediatric patient with advanced papillary thyroid carcinoma: a case report9
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovarii8
Factors Related to the Quality of Life in Children with Transfusion-Dependent Thalassemia8
Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature8
Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India7
Infectious Complications During Reinduction in Children with Relapsed Acute Lymphoblastic Leukemia: A Descriptive Analysis7
Effect of platelet count and platelet transfusion on fever duration in patients with febrile neutropenia7
The clinicopathological profile and value of multidisciplinary management of pediatric brain tumors in a low-income setting6
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children’s oncology group report6
Global caregiver concerns of SARS-CoV-2 vaccination in children with cancer: a cross-sectional mixed-methods study6
Temporal trends and unbalanced distribution, in pediatric cutaneous melanoma in 204 countries and territories, 1990-20196
How to recognize inborn errors of immunity in a child presenting with a malignancy: guidelines for the pediatric hemato-oncologist6
Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument6
The relationship between circulating tumor cells in peripheral blood and clinical characteristics of pediatric neuroblastoma and prognostic evaluation5
Impact of minimal residual disease on relapse in childhood acute lymphoblastic leukemia: Lessons learnt from a tertiary cancer center in India5
Co-transplantation of umbilical cord mesenchymal stem cells and peripheral blood stem cells in children and adolescents with refractory or relapsed severe aplastic anemia5
Advancing the Care of Pediatric Rare Solid Tumors: A virtual rare tumor board5
Comparative analysis of a novel next-generation sequencing-based IGH clonality assay for measurable residual disease detection in pediatric B-cell acute lymphoblastic leukemia patients5
Acute myeloid leukemia in a child with familial platelet disorder and a cryptic runx1 intragenic deletion5
Clinical profile and outcome of children with anaplastic large cell lymphoma treated with short-course chemotherapy – ten years experience from a tertiary care center in a LMIC5
Impact of restrictive measures due to the Covid-19 pandemic on the incidence of immune thrombocytopenia in children: an Italian single center experience5
Gross motor disorders in pediatric patients with acute lymphoblastic leukemia and survivors: A systematic review5
Methotrexate concentrations and associated variability factors in high dose therapy of children with acute lymphoblastic leukemia and non-Hodgkin lymphoma5
Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study5
Prevalence and Risk Factors for Pulmonary Embolism in Pediatric Sickle Cell Disease: A National Administrative Database Study5
Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review4
The efficacy of oral L-arginine therapy for the treatment of vaso-occlusive pain episodes in children with sickle cell disease4
Substrate oxidation during exercise in childhood acute lymphoblastic leukemia survivors4
The Onset of Puberty Presents Unique Management Issues in Penile Chronic Graft-versus-Host Disease Requiring Circumcision in Male Pediatric Patients4
Letter to editor regarding “Clinical practice guidelines on management of infantile hemangioma: a systematic quality appraisal using the AGREE II instrument”4
Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome4
Pediatric AML: state of the Art and Future Directions4
Application of microRNAs in the diagnosis and monitoring of pediatric germ cell tumors: Kazakh experience4
Changes in anthropometrical status and body composition in children with cancer during initial chemotherapy4
Safety and Tolerability of a 3-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients: Results of an Open-Label, Single-Arm Phase 4 Trial4
Psychosocial and mental profile of children with sickle cell disease and their caregivers4
Interaction between CASP8AP2 and ZEB2-CtBP2 Regulates the Expression of LEF14
Reducing empiric antibiotic administration in pediatric oncology patients with non-neutropenic fever: a single-center quality improvement initiative4
Haploidentical hematopoietic cell transplant for severe aplastic anemia in children with carbapenem-resistant enterocolitis4
The efficacy and safety of midazolam with fentanyl versus midazolam with ketamine for bedside invasive procedural sedation in pediatric oncology patients: A randomized, double-blinded, crossover trial4
German physicians’ perceptions and views on complementary medicine in pediatric oncology: a qualitative study3
Sickle-Cell Disease and Stroke: Quality of Life of Patients in a Chronic Transfusion Regimen from the Caregivers’ Perspective3
Characterizing age-related differences in Hodgkin lymphoma in children, adolescents and young adults3
Sexual activity in young adult survivors of childhood cancer: a population-based study3
Hematopoietic Stem Cell Transplantation in Children with Sickle Cell Disease and Thalassemia Major: A National Database Study3
Vitamin D deficiency in a pediatric population with sickle cell disease3
Post-transplant CD34+ selected stem cell boost as an intervention for declining mixed chimerism following reduced intensity conditioning allogeneic stem cell transplant in children and young adults wi3
A case control analysis of pattern and risk factors for pulmonary dysfunction amongst childhood cancer survivors: a single centre study from a low-middle income setting3
The effects of NUDT15 and TPMT variants on mercaptopurine treatment in Vietnamese pediatric acute lymphoblastic leukemia patients3
Hospital acquired venous thromboembolism in children with sickle cell disease3
Assessment of depression in children and adolescents with sickle cell anemia in a low-resource setting: a comparative study3
Specific cytokine patterns in Epstein-Barr virusassociated hemophagocytic lymphohistiocytosis compared to Kawasaki disease in children3
Potential role of serum vitamin D as a risk factor in pediatric acute lymphoblastic leukemia3
Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation3
Prospective Evaluation of KIT Mutations and Long-Term Outcomes in Pediatric Core Binding Factor Acute Myeloid Leukemia: A Single Institutional Study in C3
Access to Methotrexate Monitoring in Latin America: A Multicountry Survey of Supportive Care Capacity3
Gonadal health in recipients of nonmyeloablative hematopoietic stem cell transplantation in children and adolescents with sickle cell disease3
0.41469287872314